NCW visits TCS Nashik: What the fact-finding committee will examine and why its report matters beyond this case
Read More Pharma Industry News Can the Barinthus–Clywedog merger reshape diabetes and autoimmune drug pipelines? Barinthus Biotherapeutics merges with Clywedog Therapeutics in an all-stock deal. Explore the impact on diabetes, celiac drug pipelines, and BRNS stock. byPallavi MadhirajuSeptember 30, 2025